Identification of multiple genetic loci that regulate adenovirus gene therapy
- 18 December 2003
- journal article
- Published by Springer Nature in Gene Therapy
- Vol. 11 (1) , 4-14
- https://doi.org/10.1038/sj.gt.3302136
Abstract
A key aspect of the immune response to adenovirus (Ad) gene therapy is the generation of a cytotoxic T-cell (CTL) response. To better understand the genetic network underlying these events, 20 strains of C57BL/6 DBA/2 (BXD) recombinant inbred (RI) mice were administered with AdLacZ and analyzed at days 7, 21, 30, and 50 for liver -galactosidase (LacZ) expression and CTL response. Sera levels of interferon gamma (IFN-), tumor necrosis factor- (TNF-), and interleukin-6 (IL-6) were analyzed at different times after AdLacZ. There was a distinct strain-dependent expression of LacZ, which was strongly correlated with the CTL response. Among the five BXD RI strains that exhibited significantly prolonged LacZ expression, four also exhibited a marked defect in the production of Ad-specific CTL. There was a strong correlation between the sera levels of IFN-, TNF-, and IL-6, but cytokine responses were not significantly correlated with LacZ expression or the CTL response. Quantitative trait loci regulating LacZ on day 30 were found on chromosome (Chr) 19 (33 cM) and Chr 15 (42.8 cM). Cytotoxicity mapped to Chr 7 (41.0 and 57.4–65.2 cM), Chr 15 (61.7 cM), and Chr X (27.8 cM). IFN- production mapped to Chr 18 (22, 27, and 32 cM) and Chr 11 (64.0 cM). TNF- and IL-6 production mapped to Chr 6 (91.5 cM) Chr 9 (42.0 cM) and Chr 8 (52 and 73.0 cM). These results indicate that different strains of mice exhibit different pathways for effective clearance of AdLacZ depending on genetic polymorphisms and interactions at multiple genetic loci.Keywords
This publication has 59 references indexed in Scilit:
- Hepatic DR5 Induces Apoptosis and Limits Adenovirus Gene Therapy Product Expression in the LiverJournal of Virology, 2002
- Transient blocking of both B7.1 (CD80) and B7.2 (CD86) in addition to CD40–CD40L interaction fully abrogates the immune response following systemic injection of adenovirus vectorGene Therapy, 2002
- Variation in Adenovirus Transgene Expression between BALB/c and C57BL/6 Mice Is Associated with Differences in Interleukin-12 and Gamma Interferon Production and NK Cell ActivationJournal of Virology, 2001
- Transient depletion of CD4 lymphocyte improves efficacy of repeated administration of recombinant adenovirus in the ornithine transcarbamylase deficient sparse fur mouseGene Therapy, 2000
- Immunomodulation and Adenoviral Gene Transfer to the Lungs of Nonhuman PrimatesHuman Gene Therapy, 2000
- Use of helper-dependent adenoviral vectors of alternative serotypes permits repeat vector administrationGene Therapy, 1999
- Identification of a Locus on Distal Mouse Chromosome 12 That Controls Resistance to Tumor Necrosis Factor-Induced Lethal ShockGenomics, 1999
- Antibody to CD40 ligand inhibits both humoral and cellular immune responses to adenoviral vectors and facilitates repeated administration to mouse airwayGene Therapy, 1997
- Adenovirus-mediated gene transfer: influence of transgene, mouse strain and type of immune response on persistence of transgene expressionGene Therapy, 1997
- Genetic dissection of complex traits: guidelines for interpreting and reporting linkage resultsNature Genetics, 1995